Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. Getting an ...

Conclusions: Prevalence of obesity is increasing, and use of GLP-1 RAs as the preferred antiobesity medication has increased ...

Here, we look at the clinical stories patients might be reading in the mainstream news media and provide the original ...

Healthcare today is undergoing a quiet transformation, one driven not by hospital expansions or new pharmaceuticals, but by ...

Friday, April 10, the William & Mary Scholars Undergraduate Research Experience hosted the College of William and Mary’s ...

Researchers discovered an appetite-suppressing molecule in python blood. If one day turned into a medication, it might lack ...

Join Mark from Self Sufficient Me as he shares an unexpected backyard encounter involving his dog, Scooter, and a large ...

As deaths from diabetes start to rival those from infectious threats like malaria, a new form of the condition linked to malnutrition is surfacing in patients who can afford neither screening nor care ...

When Sam Glassenberg’s 5-year-old daughter was diagnosed with Type 1 diabetes, the veteran video game developer found himself facing a terrifying new reality: Becoming his child’s stand-in “pancreas,” ...

Retatrutide, an experimental diabetes drug, reduced A1C levels by 2 percent and body weight by 17 percent in a new late-stage trial. Unlike rival medications, which target one or two hormone receptors ...